title: Carcinosarcoma of the ovary a review.
abstract: Carcinosarcoma of the ovary, also referred to as mixed mullerian tumor of the ovary, is a rare and aggressive tumor. This tumor type is unique in that it contains malignant epithelial and stromal elements. The average survival for a woman diagnosed with carcinosarcoma of the ovary is less than 2 years. Due to the rarity of this tumor, the optimal treatment for carcinosarcoma of the ovary has not been determined. We review the pathology, risk factors, and current treatment recommendations for carcinosarcoma of the ovary.
authors.affiliation: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC 27599, USA.
authors.forename: Leigh A
authors.initials: LA
authors.lastname: Cantrell
authors.forename: Linda
authors.initials: L
authors.lastname: Van Le
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D002296:Carcinosarcoma / Q000097:blood / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000235:genetics / Q000473:pathology / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor